biogen bgnf patent european office biogen european patent office grant patent cover protein produce hepatitis vaccine genetic engineer technique robert gottlieb biogen spokesman company license vaccine nonexclusive basis wellcome plc british pharmaceutical firm discuss license company biogen patent exclude market hepatitis vaccine country european patent convention gottlieb company file patent market include vaccine clinical test patent biotechnology field particularly company exclusive patent reap reward recently product genetic engineer target patent lawsuit merck mrk sell genetically engineer hepatitis vaccine call recombivax hb subsidiary smithkline beckman smithkline biologicals base belgium sell hepatitis vaccine call engerixb belgium smithkline spokesman vaccine formally approve switzerland luxembourg authorize market country hepatitis serious liver infection common africa southeast asia pct pct population carry virus occur december european patent ofice reject biogen patent alphainterferon biogen appeal receive formal write opinion office 
